344 related articles for article (PubMed ID: 8162353)
1. Antiendotoxin therapies for septic shock.
Corriveau CC; Danner RL
Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin as a therapeutic target in septic shock.
Corriveau CC; Danner RL
Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
[TBL] [Abstract][Full Text] [Related]
3. Current prospects for the treatment of clinical sepsis.
Suffredini AF
Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
[TBL] [Abstract][Full Text] [Related]
4. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
Barriere SL; Guglielmo BJ
Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
[TBL] [Abstract][Full Text] [Related]
5. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic effects of endotoxin.
Zivot JB; Hoffman WD
New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
[TBL] [Abstract][Full Text] [Related]
7. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
Rubin RM; Noland J; Rosenbaum JT
Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
[TBL] [Abstract][Full Text] [Related]
8. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Gorelick KJ; Chmel H
Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
[TBL] [Abstract][Full Text] [Related]
9. Antiendotoxin therapy in sepsis.
Colletti RC; Dew RB; Goulart AE
Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040
[TBL] [Abstract][Full Text] [Related]
10. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
[TBL] [Abstract][Full Text] [Related]
11. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
Opal SM; Yu RL
Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
13. Immunological intervention in endotoxin shock.
Ziegler EJ
Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
[No Abstract] [Full Text] [Related]
14. Endotoxin as a drug target.
Opal SM; Glück T
Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
[TBL] [Abstract][Full Text] [Related]
15. Targeting endotoxin in the treatment of sepsis.
Rachoin JS; Schorr CA; Dellinger RP
Subcell Biochem; 2010; 53():323-38. PubMed ID: 20593274
[TBL] [Abstract][Full Text] [Related]
16. Anti-endotoxin antibodies and other inhibitors of endotoxin.
Zanetti G; Glauser MP; Baumgartner JD
New Horiz; 1993 Feb; 1(1):110-9. PubMed ID: 7922383
[TBL] [Abstract][Full Text] [Related]
17. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
Abraham E
West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
[No Abstract] [Full Text] [Related]
18. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies in the treatment of sepsis and septic shock].
Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
[No Abstract] [Full Text] [Related]
20. [The application of molecular biology to anti-endotoxin therapies].
Someya T; Sasaki K; Hirata K
Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):523-6. PubMed ID: 12884777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
